Research ArticleClinical Studies
p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening
MARIA MAGKANA, PANAGIOTA MENTZELOPOULOU, EKATERINI MAGKANA, ANDREAS PAMPANOS, NIKOLAOS VRACHNIS, ELENI KALAFATI, GEORGIOS DASKALAKIS, EKATERINI DOMALI, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, NICHOLAS P. ANAGNOU and KALLIOPI I. PAPPA
Anticancer Research May 2022, 42 (5) 2599-2606; DOI: https://doi.org/10.21873/anticanres.15738
MARIA MAGKANA
1School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;
2Department of Genetics, Alexandra Hospital, Athens, Greece;
3Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
PANAGIOTA MENTZELOPOULOU
4Department of Cytology, Alexandra Hospital, Athens, Greece;
EKATERINI MAGKANA
4Department of Cytology, Alexandra Hospital, Athens, Greece;
ANDREAS PAMPANOS
2Department of Genetics, Alexandra Hospital, Athens, Greece;
NIKOLAOS VRACHNIS
5Third Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece;
ELENI KALAFATI
3Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
GEORGIOS DASKALAKIS
6First Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
EKATERINI DOMALI
6First Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
NIKOLAOS THOMAKOS
6First Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
ALEXANDROS RODOLAKIS
6First Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
NICHOLAS P. ANAGNOU
3Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
KALLIOPI I. PAPPA
3Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece;
6First Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening
MARIA MAGKANA, PANAGIOTA MENTZELOPOULOU, EKATERINI MAGKANA, ANDREAS PAMPANOS, NIKOLAOS VRACHNIS, ELENI KALAFATI, GEORGIOS DASKALAKIS, EKATERINI DOMALI, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, NICHOLAS P. ANAGNOU, KALLIOPI I. PAPPA
Anticancer Research May 2022, 42 (5) 2599-2606; DOI: 10.21873/anticanres.15738
p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening
MARIA MAGKANA, PANAGIOTA MENTZELOPOULOU, EKATERINI MAGKANA, ANDREAS PAMPANOS, NIKOLAOS VRACHNIS, ELENI KALAFATI, GEORGIOS DASKALAKIS, EKATERINI DOMALI, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, NICHOLAS P. ANAGNOU, KALLIOPI I. PAPPA
Anticancer Research May 2022, 42 (5) 2599-2606; DOI: 10.21873/anticanres.15738
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.